Search Results - "RUBIN, B. K"

Refine Results
  1. 1

    IL-13-induced MUC5AC production and goblet cell differentiation is steroid resistant in human airway cells by Kanoh, S., Tanabe, T., Rubin, B. K.

    Published in Clinical and experimental allergy (01-12-2011)
    “…Summary Background Glucocorticosteroids (GCS) are used to treat bronchial asthma, but are not uniformly effective, especially in severe asthma. IL‐13 is a T…”
    Get full text
    Journal Article
  2. 2

    Bordetella bronchiseptica in a Paediatric Cystic Fibrosis Patient: Possible Transmission from a Household Cat by Register, K. B., Sukumar, N., Palavecino, E. L., Rubin, B. K., Deora, R.

    Published in Zoonoses and public health (01-06-2012)
    “…Summary Bordetella bronchiseptica is a zoonotic respiratory pathogen commonly found in domesticated farm and companion animals, including dogs and cats. Here,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection by Bennett, W.D, Kala, A, Duckworth, H, Zeman, K.L, Wu, J, Henderson, A, Yopp, M, Rubin, B.K

    Published in Respiratory medicine (01-11-2015)
    “…Abstract Background Observational studies suggest that orally administered guaifenesin (GGE) may thin lower respiratory tract secretions but none have examined…”
    Get full text
    Journal Article
  5. 5

    Fluctuations in autonomic nervous activity during sleep displayed by power spectrum analysis of heart rate variability by BAHARAV, A, KOTAGAL, S, GIBBONS, V, RUBIN, B. K, PRATT, G, KARIN, J, AKSELROD, S

    Published in Neurology (01-06-1995)
    “…The use of an efficient noninvasive method to investigate the autonomic nervous system and cardiovascular control during sleep. Beat-to-beat heart rate…”
    Get full text
    Journal Article
  6. 6

    Nitric oxide metabolites in cystic fibrosis lung disease by Grasemann, H, Ioannidis, I, Tomkiewicz, R P, de Groot, H, Rubin, B K, Ratjen, F

    Published in Archives of disease in childhood (01-01-1998)
    “…Although the activity of nitric oxide (NO) synthases are increased in lung tissue of patients with cystic fibrosis, the concentrations of nasal and exhaled NO…”
    Get full text
    Journal Article
  7. 7

    IL-33 stimulates CXCL8/IL-8 secretion in goblet cells but not normally differentiated airway cells by Tanabe, T., Shimokawaji, T., Kanoh, S., Rubin, B. K.

    Published in Clinical and experimental allergy (01-04-2014)
    “…Summary Background IL‐13, a helper T cell type 2 (Th2) cytokine, transforms cultured airway epithelial cells to goblet cells, and this is not inhibited by…”
    Get full text
    Journal Article
  8. 8

    Rational use of mucoactive medications to treat pediatric airway disease by Linssen, R.S.N., Ma, J., Bem, R.A., Rubin, B.K.

    Published in Paediatric respiratory reviews (01-11-2020)
    “…Many airway diseases in children, notably bronchiolitis, cystic fibrosis (CF), non-CF bronchiectasis including primary ciliary dyskinesia, pneumonia, and…”
    Get full text
    Journal Article
  9. 9

    Macrolide antibiotics, bacterial populations and inflammatory airway disease by SWORDS, W. E, RUBIN, B. K

    Published in Netherlands journal of medicine (01-07-2003)
    “…Chronic obstructive pulmonary disease (COPD) and other inflammatory airway conditions are major causes of morbidity and mortality worldwide. Antibiotics are…”
    Get full text
    Journal Article
  10. 10

    Effect of clarithromycin on nasal mucus properties in healthy subjects and in patients with purulent rhinitis by Rubin, B K, Druce, H, Ramirez, O E, Palmer, R

    “…Erythromycin inhibits mucus glycoconjugate secretion from airway cells in vitro and may increase mucus clearance in patients with asthma or diffuse…”
    Get more information
    Journal Article
  11. 11

    Ring distraction technique for measuring surface tension of sputum: relationship to sputum clearability by Albers, G. M, Tomkiewicz, R. P, May, M. K, Ramirez, O. E, Rubin, B. K

    Published in Journal of applied physiology (1985) (01-12-1996)
    “…G. M. Albers, R. P. Tomkiewicz, M. K. May, O. E. Ramirez, and B. K. Rubin Saint Louis University School of Medicine, Department of Pediatrics at Cardinal…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Alternative mechanisms for tiotropium by Bateman, E.D, Rennard, S, Barnes, P.J, Dicpinigaitis, P.V, Gosens, R, Gross, N.J, Nadel, J.A, Pfeifer, M, Racké, K, Rabe, K.F, Rubin, B.K, Welte, T, Wessler, I

    Published in Pulmonary pharmacology & therapeutics (01-12-2009)
    “…Abstract Tiotropium is commonly used in the treatment of chronic obstructive pulmonary disease. Although largely considered to be a long-acting bronchodilator,…”
    Get full text
    Journal Article
  14. 14

    Exogenous surfactant enhances mucociliary clearance in the anaesthetized dog by De Sanctis, GT, Tomkiewicz, RP, Rubin, BK, Schurch, S, King, M

    Published in The European respiratory journal (01-09-1994)
    “…Therapy with exogenous surfactants is currently used for the treatment of respiratory distress syndrome of the newborn (RDS) and is under investigation for…”
    Get full text
    Journal Article
  15. 15

    Mucus-depleted frog palate as a model for the study of mucociliary clearance by Rubin, B K, Ramirez, O, King, M

    Published in Journal of applied physiology (1985) (01-08-1990)
    “…To better understand the frog palate model of mucociliary transport, we measured the transport rate of mucus (MTR) from the leopard frog, Rana pipiens, and…”
    Get more information
    Journal Article
  16. 16

    Effects of Aerosolized Surfactant in Patients With Stable Chronic Bronchitis: A Prospective Randomized Controlled Trial by Anzueto, Antonio, Jubran, Amal, Ohar, Jill A, Piquette, Craig A, Rennard, Stephen I, Colice, Gene, Pattishall, Edward N, Barrett, Janet, Engle, Melissa, Perret, Kenneth A, Rubin, Bruce K

    “…CONTEXT. —Chronic bronchitis, estimated to affect more than 13 million adults in the United States, is characterized in part by retention of airway secretions,…”
    Get full text
    Journal Article
  17. 17

    An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol by Rubin, B K

    Published in Chest (01-07-1999)
    “…The mechanism of action of potential mucoactive agents could relate to effects on the mucociliary apparatus or to direct effects on the secretions. The purpose…”
    Get more information
    Journal Article
  18. 18
  19. 19

    Exposure of Children with Cystic Fibrosis to Environmental Tobacco Smoke by Rubin, Bruce K

    Published in The New England journal of medicine (20-09-1990)
    “…Exposure to environmental tobacco smoke has been postulated to have an adverse effect on lung function 1 2 3 4 and growth 5 6 7 8 9 10 11 in normal children…”
    Get full text
    Journal Article
  20. 20